Korenko Michael K purchased $100K of RDGL
Korenko Michael K (CEO) purchased 200,000 shares of VIVOS INC (RDGL) at $0.50 on 2026-09-30.
How this was made
The 30-second read
Why it matters
The CEO's purchase adds a modest bullish signal but is unlikely to move the stock significantly given its small size.
Market read
Primary insider purchase filing; modest relevance for short‑term traders monitoring insider sentiment.
What to watch
The transaction represents less than 0.1% of outstanding shares, limiting its price influence.
Background
Form 4 filings disclose insider transactions and are primary sources for such activity.
Ticker impact
CEO Michael K. Korenko purchased 200,000 shares of Vivos Inc (RDGL) at $0.498 per share, a $99.6K open‑market buy on 2026‑09‑30.
likely slight price support as the market absorbs the insider purchase
The transaction size is modest relative to market cap, but insider purchases are generally viewed positively by traders.
Market effects
Minimal impact on the broader biotech sector; the filing is company‑specific.
No discernible regional effect.
Limited to investors tracking insider activity in Vivos Inc.
Counterpoint
The purchase may be routine portfolio rebalancing and not indicative of material insight.
Key entities
- CompanyVivos Inc
Biotech firm listed on NASDAQ under ticker RDGL.
- PersonMichael K. Korenko
CEO of Vivos Inc who executed the insider purchase.